Integrated Biopharma, Inc.
INBP
$0.30
$0.00-0.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.31M | 4.73M | 3.62M | 2.96M | 2.46M |
| Total Receivables | 3.59M | 3.98M | 5.43M | 5.08M | 4.23M |
| Inventory | 8.36M | 10.47M | 9.36M | 10.08M | 11.07M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 550.00K | 440.00K | 356.00K | 428.00K | 398.00K |
| Total Current Assets | 17.82M | 19.62M | 18.76M | 18.55M | 18.15M |
|
|
|||||
| Total Current Assets | 17.82M | 19.62M | 18.76M | 18.55M | 18.15M |
| Net Property, Plant & Equipment | 2.29M | 2.60M | 2.75M | 2.95M | 3.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.44M | 3.32M | 3.39M | 4.16M | 4.41M |
| Total Assets | 23.55M | 25.54M | 24.90M | 25.66M | 25.66M |
|
|
|||||
| Total Accounts Payable | 2.14M | 2.80M | 2.27M | 2.50M | 2.81M |
| Total Accrued Expenses | 1.13M | 1.49M | 1.30M | 1.64M | 1.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 267.00K | 474.00K | 679.00K | 844.00K | 964.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.54M | 4.76M | 4.25M | 4.98M | 5.58M |
|
|
|||||
| Total Current Liabilities | 3.54M | 4.76M | 4.25M | 4.98M | 5.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 237.00K | 287.00K | 336.00K | 292.00K | 359.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.78M | 5.05M | 4.58M | 5.27M | 5.93M |
|
|
|||||
| Common Stock & APIC | 51.93M | 51.88M | 51.84M | 51.72M | 51.68M |
| Retained Earnings | -32.06M | -31.30M | -31.42M | -31.24M | -31.85M |
| Treasury Stock & Other | -98.00K | -99.00K | -99.00K | -99.00K | -99.00K |
| Total Common Equity | 19.77M | 20.49M | 20.32M | 20.38M | 19.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.77M | 20.49M | 20.32M | 20.38M | 19.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.77M | 20.49M | 20.32M | 20.38M | 19.73M |
|
|
|||||